INT251834
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Despite lack of data, it may also be speculated that an increased level of angiogenin in the circulating blood or peritoneal fluid promote the establishment of endometriotic lesions in the pelvic cavity, and once endometriotic lesions have been established and progressed to advanced stage, unknown adverse events, such as impairment of luteal steroidogenesis or release of local inflammatory mediators inhibiting response to progesterone, reduce the expression of angiogenin in the eutopic endometrium. | |||||||||||||||
| |||||||||||||||
|
It is possible that a relative deficiency of angiogenin expression in patients with advanced stage endometriosis leads to a defect in the angiogenic process that is essential for successful implantation. | |||||||||||||||
| |||||||||||||||
|
At present, however, it is unclear whether the relative deficiency of angiogenin expression in the secretory phase is inherent to the eutopic endometrium itself or the secondary consequence of other factors associated with ovarian endometrioma. | |||||||||||||||
| |||||||||||||||
|
Although further studies are required to elucidate the relevance of angiogenin to the process of implantation, these findings suggest that the relative deficiency of angiogenin expression could be one of the critical factors involved in the mechanism by which endometriosis impairs fertility.
| |||||||||||||||
| |||||||||||||||
|
Despite these limits, we have found that the expression of angiogenin is decreased in the eutopic endometrium from women with advanced stage endometriosis during the normal window of implantation. | |||||||||||||||
| |||||||||||||||
|
These findings suggest that the relative deficiency of angiogenin expression in the secretory endometrium could impair implantation in women with advanced stage endometriosis.
| |||||||||||||||
| |||||||||||||||
|
Based upon the specific enhancement of angiogenin expression around the implantation window period along with its strong angiogenic activity, it is necessary to investigate whether the expression of angiogenin in the eutopic endometrium is different between women with and without endometriosis. | |||||||||||||||
| |||||||||||||||
|
The low levels of Ang-(17) and ACE2 in the RUPP model may represent an inhibition of the vasodilator arm of the renin-angiotensin system associated with factors generated by the reduced placental blood flow (sFlt-1, TNF-? | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.